Long-term follow-up of patients with sirolimus-eluting stents for treatment of bare-metal in-stent restenosis

International Journal of Cardiology

Volumn 140, Issue 2, 2010, Pages 219-225

  Le Feuvre, Claude ^a   Healy Brucker, Aude ^a   Helft, Gérard ^a   Monségu, Jacques ^b   Varenne, Olivier ^c   Spaulding, Christian ^c   Collet, Jean P ^a   Beygui, Farzin ^a   Barthélémy, Olivier ^a   Choussat, Rémi ^a   Montalescot, Gilles ^a   Metzger, Jean Philippe ^a  

^a PITIÉ SALPÊTRIÈRE HOSPITAL   (France)

^b University of Paris Descartes   (France)

^c Institut Cochin   (France)

Author keywords

Coronary angioplasty; Drug eluting stent; Restonosis

Indexed keywords

RAPAMYCIN;

ADULT; AGED; ARTICLE; BARE METAL STENT; CONTROLLED STUDY; DRUG ELUTING STENT; FEMALE; FOLLOW UP; HUMAN; MAJOR CLINICAL STUDY; MALE; PERCUTANEOUS CORONARY INTERVENTION; PRIORITY JOURNAL; RESTENOSIS; REVASCULARIZATION; STENT THROMBOSIS; TRANSLUMINAL CORONARY ANGIOPLASTY;

AGED; ANGINA, UNSTABLE; ANGIOPLASTY, TRANSLUMINAL, PERCUTANEOUS CORONARY; CORONARY ARTERY DISEASE; CORONARY RESTENOSIS; CORONARY THROMBOSIS; DRUG-ELUTING STENTS; FEMALE; FOLLOW-UP STUDIES; HUMANS; IMMUNOSUPPRESSIVE AGENTS; MALE; METALS; MIDDLE AGED; PREDICTIVE VALUE OF TESTS; REGISTRIES; RISK FACTORS; SIROLIMUS; TIME FACTORS;

EID: 77950339421     PISSN: 01675273     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijcard.2008.11.029     Document Type: Article

References (18)

1. Chen M.S., John J.M., Chew D.P., Lee D.S., Ellis S.G., and Bhatt D.L. Bare metal stent restenosis is not a benign clinical entity. Am Heart J 151 (2006) 1260-1264
2. Dibra A., Kastrati A., Alfonso F., et al. Effectiveness of drug-eluting stents in patients with bare-metal in-stent restenosis. J Am Coll Cardiol 49 (2007) 616-623
3. Holmes D.R., Teirstein P., Satler L., et al. Sirolimus-eluting stents vs vascular brachytherapy for in-stent restenosis within bare-metal stents: the SISR randomized trial. JAMA 295 (2006) 1264-1273
4. Degertekin M., Regar E., Tanabe K., et al. Sirolimus-eluting stent for treatment of complex in-stent restenosis. J Am Coll Cardiol 41 (2003) 184-189
5. Kastrati A., Mehilli J., von Beckerath N., et al. ISAR-DESIRE Study Investigators. Sirolimus-eluting stent or paclitaxel-eluting stent vs balloon angioplasty for prevention of recurrences in patients with coronary in-stent restenosis: a randomized controlled trial. JAMA 293 (2005) 165-171
6. Saia F., Lemos P.A., Arampatzis C.A., et al. Routine sirolimus eluting stent implantation for unselected in-stent restenosis: insights from the rapamycine eluting stent evaluated at Rotterdam cardiology hospital (RESARCH) registry. Heart 90 (2004) 1183-1188
7. Fujii K., Mintz G.S., Kobayashi Y., et al. Contribution of stent underexpansion to recurrence after sirolimus-eluting stent implantation for in-stent restenosis. Circulation 109 (2004) 1085-1088
8. Stone G.W., Moses J.W., Ellis S.G., et al. Safety and efficacy of sirolimus- and paclitaxel-eluting coronary stents. N Engl J Med 356 (2007) 998-1008
9. Mehran R., Dangas G., Abizaid A.S., et al. Angiographic patterns of in-stent restenosis: classification and implications for long-term outcome. Circulation 100 (1999) 1872-1878
10. Cutlip D.E., Windecker S., Meshran R., et al. Clinical end points in coronary stent trials: a case for standardized definitions. Circulation 115 (2007) 2344-2351
11. Spaulding C., Daeman J., Boersma E., Cutlip D.E., and Serruys P.W. A pooled analysis of data comparing sirolimus-eluting stents with bare-metal stents. N Engl J Med 256 (2007) 989-997
12. Saia F., Lemos P.A., Hoye A., et al. Clinical outcome for sirolimus-eluting stent implantation and vascular brachytherapy for the treatment of in-stent restenosis. Catheter Cardiovasc Interv 62 (2004) 283-288
13. Le Feuvre C., Montalescot G., Rosey G., et al. Predictive factors of cardiac events after implantation of sirolimus-eluting stents for treatment of in-stent restenosis. Int J Cardiol 109 (2006) 207-212
14. Roy P., Steinberg D.H., Sushinsky S.J., et al. The potential clinical utility of intravascular ultrasound guidance in patients undergoing percutaneous coronary intervention with drug-eluting stents. Eur Heart J 29 15 (2008) 1851-1857
15. Eltchaninoff H., Koning R., Tron C., et al. Balloon angioplasty for the treatment of coronary in-stent restenosis: immediate results and 6-month angiographic recurrent restenosis rate. J Am Coll Cardiol 32 (1998) 980-984
16. Adamian M., Colombo A., Briguori C., et al. Cutting balloon angioplasty for treatment of in-stent restenosis: a matched comparison with rotational atherectomy, additional stent implantation or balloon angioplasty. J Am Coll Cardiol 38 (2001) 672-679
17. Park S.W., Hong M.K., Moon D.H., et al. Treatment of diffuse in-stent restenosis with rotational atherectomy followed by radiation therapy with a rhenium-188-mercaptoacetyltriglyceride-filled balloon. J Am Coll Cardiol 38 (2001) 631-637
18. Coats A.J. Ethical authorship and publishing. Int J Cardiol 131 (2009) 149-150